Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.42 USD | +0.50% | -0.91% | -8.37% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.41% | 17.96B | |
-5.07% | 181B | |
+2.45% | 112B | |
-2.64% | 67.92B | |
+4.73% | 50.1B | |
+8.10% | 44.27B | |
+9.39% | 40.41B | |
+24.67% | 31.95B | |
-0.21% | 25.82B | |
+17.27% | 25.29B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Transcript : Baxter International Inc., Q4 2023 Earnings Call, Feb 08, 2024